AUTHORS
Pranali Manjrekar, MS, Nathan Luebbering, MS2, Cuiqing Fan, PhD3, James Johnson, BS4, Aaron Webster, MS5, Lauren Strecker, BS6, Lucille Giordullo, BS7, Sheyar Abdullah, BS8, Assem Ziady, PhD9, Azada Ibrahimova, MD10, Kasiani C. Myers I, MD11, Pooja Khandelwal, MD12, Anthony Sabulski, MD13, Yi Zheng, PhD14, Stella M Davies, MBBS, PhD15
AFFILIATIONS
1 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
2 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
3 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
4 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
5 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
6 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
7 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
8 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
9 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
10 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
11 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
12 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
13 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
14 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
15 Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
ABSTRACT
Background: Hematopoietic stem and progenitor cell (HSPC) homeostasis depends on coordinated regulation of cell proliferation, genome integrity, and inflammatory signaling. Caspase 8 associated protein 2 (Casp8ap2) is a multifunctional scaffold protein involved in histone mRNA processing, DNA replication, apoptosis, and inflammatory signaling. We hypothesized that Casp8ap2 plays a role in HSPC homeostasis.
Objective: To determine the role of Casp8ap2 in maintaining hematopoietic stem and progenitor cell homeostasis by characterizing the hematopoietic phenotype associated with its deletion.
Methods: Casp8ap2 flx/flx mice were generated by gene targeting to insert loxP sequences flanking exon 5. Bone marrow from RosaCreER; Casp8ap2 flx/flx donor HSPC were transplanted into lethally irradiated BoyJ recipient mice (n=6). Control recipients (n=6) received bone marrow from Casp8ap2 flx/flx donor mice lacking Cre. Following hematopoietic reconstitution, tamoxifen was administered for 5 consecutive days to induce Casp8ap2 deletion, verified by PCR genotyping. Four days after the last injection, peripheral blood counts, multiparameter flow cytometry, and RNA sequencing of lineage-negative LK (Lin-Sca-1-c-Kit+) and LSK (Lin-Sca-1+c-Kit+) populations were performed.
Results: Casp8ap2 deficiency rapidly disrupted hematopoietic homeostasis. Four days after the last tamoxifen treatment, recipient mice developed anemia (Hgb: 5.7 ± 0.9 vs. 10.6 ± 0.5 g/dL; p = 0.002), leukopenia (WBC: 3.2 ± 1.4 vs. 6.7 ± 2.4 x103/µL; p= 0.02), reduced neutrophil (ANC: 0.2 ± 0.1 vs. 1.4 ± 0.7 x 103/µL; p = 0.002) and monocyte counts (AMC: 0.05 ± 0.03 vs. 0.3 ± 0.1 x 103/µL; p= 0.002) and increased platelet counts (2,017 vs. 1,170 x 103/µL). Total bone marrow cellularity decreased by 65.5% (50 x 106 vs. 145 x 106 cells), and a reduced spleen index (27 vs.67; p= 0.002) was seen in the KO compared to controls. The KO mice died 5-10 days post-tamoxifen induction. Bone marrow histology confirmed markedly reduced hematopoietic cellularity and bone marrow failure. Flow cytometric analysis demonstrated selective depletion of hematopoietic progenitors with a significant loss of LK cells (9,171 vs. 2,21,737 cells; p=0.002) despite relative preservation of the LSK compartment (16,338 vs. 12,693 cells; p>0.99). Common myeloid progenitors (CMPs; 2.0 ± 1.0 vs. 12.3 ± 2.9 %; p<0.0001) and megakaryocyte-erythroid progenitors (MEPs; 10.4 ± 6.9 vs 71.0 ± 8.2 %; p<0.0001) exhibited pronounced decrease, whereas granulocyte-monocyte progenitors (GMPs; 50.5 ± 7.2 vs 10.7 ± 4.3 %; p<0.0001) and the CD34-CD16/32+ LK cells (31.9 ± 5.0 vs 2.0 ± 1.5 %; p<0.0001) were increased, indicating altered progenitor differentiation consistent with stress hematopoiesis. Significant apoptosis in various HSPC subpopulations accompanied the above phenotypic manifestations.
RNA sequencing demonstrated clear segregation of knockout and control samples, indicating robust transcriptional reprogramming following Casp8ap2 deletion. LK progenitors demonstrated prominent dysregulation of histone gene clusters together with activation of replication stress and DNA damage response programs, including increased expression of p21 (Cdkn1a) and H2afx, p53 associated apoptotic genes (Perp and Phlda1), and myeloid associated genes (Id1 and Alox5). Pathway analysis demonstrated activation of TNF/NF-kB, IL-1, IL-6, IFN-γ, and STAT3 signaling, consistent with inflammatory activation associated with stress hematopoiesis. Despite relative preservation of the LSK compartment, transcriptomic analysis demonstrated activation of replication stress, growth factor/MAPK signaling, extracellular matrix remodeling, and altered stem cell-niche interaction pathways, suggesting that surviving HSPCs transition from quiescence to stress-adapted state. Collectively, these findings suggest that Casp8ap2 deficiency disrupts hematopoiesis through coordinated replication stress and inflammatory activation, promoting stress hematopoiesis at the expense of balanced hematopoietic differentiation.
Conclusions: Casp8ap2 is a critical regulator of hematopoietic stem and progenitor cell homeostasis. Loss of Casp8ap2 promotes replication stress and inflammatory activation, disrupting progenitor survival and maintenance, and driving stress hematopoiesis leading to bone marrow failure. Our findings identify Casp8ap2 as a previously unrecognized regulator of hematopoiesis and provide insight into the mechanisms that regulate HSPC function.
DISCLOSURES
Pranali Manjrekar, MS: No relevant conflicts of interest to declare.